345 related articles for article (PubMed ID: 23324907)
21. Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease.
Kilciler G; Genc H; Tapan S; Ors F; Kara M; Karadurmus N; Ercin CN; Karslioglu Y; Kilic S; Bagci S; Erbil MK; Dogru T
Ups J Med Sci; 2010 Nov; 115(4):253-9. PubMed ID: 20731535
[TBL] [Abstract][Full Text] [Related]
22. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
[TBL] [Abstract][Full Text] [Related]
23. Subclinical hypothyroidism as a risk factor for the development of cardiovascular disease in obese adolescents with nonalcoholic fatty liver disease.
Sert A; Pirgon O; Aypar E; Yilmaz H; Odabas D
Pediatr Cardiol; 2013 Jun; 34(5):1166-74. PubMed ID: 23344895
[TBL] [Abstract][Full Text] [Related]
24. FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis.
Tan M; Korkmaz H; Aydın H; Kumbul Doğuç D
Turk J Med Sci; 2019 Oct; 49(5):1490-1497. PubMed ID: 31651119
[TBL] [Abstract][Full Text] [Related]
25. Serum Heart Type Fatty Acid Binding Protein Levels in Prediabetes-An Invaluable Cardiovascular Biomarker.
Ramesh P; Chauhan A; Goyal P; Singh A; Singhal A; Gupta A
J Assoc Physicians India; 2020 Apr; 68(4):42-46. PubMed ID: 32610846
[TBL] [Abstract][Full Text] [Related]
26. Circulating adipocyte fatty acid-binding protein levels predict the development of subclinical atherosclerosis in type 2 diabetes.
Xiao Y; Xiao X; Xu A; Chen X; Tang W; Zhou Z
J Diabetes Complications; 2018 Dec; 32(12):1100-1104. PubMed ID: 30314766
[TBL] [Abstract][Full Text] [Related]
27. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
28. Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability.
Liu YC; Hung CS; Wu YW; Lee YC; Lin YH; Lin C; Lo MT; Chan CC; Ma HP; Ho YL; Chen CH
PLoS One; 2013; 8(4):e61803. PubMed ID: 23626730
[TBL] [Abstract][Full Text] [Related]
29. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
30. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.
Di Costanzo A; D'Erasmo L; Polimeni L; Baratta F; Coletta P; Di Martino M; Loffredo L; Perri L; Ceci F; Montali A; Girelli G; De Masi B; Angeloni A; Catalano C; Maranghi M; Del Ben M; Angelico F; Arca M
Atherosclerosis; 2017 Feb; 257():232-239. PubMed ID: 28027788
[TBL] [Abstract][Full Text] [Related]
31. Atherosclerosis and Associated Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Bajaj S; Prajapati SK
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702845
[TBL] [Abstract][Full Text] [Related]
32. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
33. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation.
Akın L; Kurtoglu S; Yikilmaz A; Kendirci M; Elmalı F; Mazicioglu M
Acta Paediatr; 2013 Mar; 102(3):e107-13. PubMed ID: 23190373
[TBL] [Abstract][Full Text] [Related]
34. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
[TBL] [Abstract][Full Text] [Related]
36. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
[TBL] [Abstract][Full Text] [Related]
37. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis.
Yeung DC; Xu A; Cheung CW; Wat NM; Yau MH; Fong CH; Chau MT; Lam KS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1796-802. PubMed ID: 17510463
[TBL] [Abstract][Full Text] [Related]
38. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound.
Miyoshi T; Onoue G; Hirohata A; Hirohata S; Usui S; Hina K; Kawamura H; Doi M; Kusano KF; Kusachi S; Ninomiya Y
Atherosclerosis; 2010 Jul; 211(1):164-9. PubMed ID: 20193950
[TBL] [Abstract][Full Text] [Related]
39. Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults.
Liu Y; Liu C; Shi X; Lin M; Yan B; Zeng X; Chen N; Lu S; Liu S; Yang S; Li X; Li Z
J Diabetes; 2017 Jun; 9(6):586-595. PubMed ID: 27371101
[TBL] [Abstract][Full Text] [Related]
40. Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
Arai T; Atsukawa M; Tsubota A; Kato K; Abe H; Ono H; Kawano T; Yoshida Y; Tanabe T; Okubo T; Hayama K; Nakagawa-Iwashita A; Itokawa N; Kondo C; Kaneko K; Emoto N; Nagao M; Inagaki K; Fukuda I; Sugihara H; Iwakiri K
Sci Rep; 2021 Aug; 11(1):15938. PubMed ID: 34354193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
